Targeting tumor vascularization: promising strategies for vascular normalization Ruiqi ZhengFeifan LiAihua Gong Review – Cancer Research 19 June 2021 Pages: 2489 - 2505
Cannabinoids in the landscape of cancer Nagina MangalSimon ErridgeMikael Hans Sodergren Review – Cancer Research Open access 14 July 2021 Pages: 2507 - 2534
Cytoplasmic LXR expression is an independent marker of poor prognosis for patients with early stage primary breast cancer Wanting ShaoChristina KuhnSophie Sixou Original Article – Cancer Research Open access 03 June 2021 Pages: 2535 - 2544
Correction to: Cytoplasmic LXR expression is an independent marker of poor prognosis for patients with early stage primary breast cancer Wanting ShaoChristina KuhnSophie Sixou Correction 16 July 2021 Pages: 2545 - 2546
Why so few Nobel Prizes for cancer researchers? An analysis of Nobel Prize nominations for German physicians with a focus on Ernst von Leyden and Karl Heinrich Bauer Nils HanssonGiacomo PadriniCarsten Timmermann Original Article – Cancer Research Open access 29 May 2021 Pages: 2547 - 2553
Expression of estrogen-related receptors in ovarian cancer and impact on survival Susanne Schüler-ToprakFlorian WeberOliver Treeck Original Article – Cancer Research Open access 05 June 2021 Pages: 2555 - 2567
The prognostic significance of PD-L1 expression on tumor and immune cells in Merkel cell carcinoma Morgan GuénoléPaolo BénigniUlrike Schick Original Article – Cancer Research 11 June 2021 Pages: 2569 - 2578
PARP inhibition in UV-associated angiosarcoma preclinical models Marije E. WeidemaIngrid M. E. DesarYvonne M. H. Versleijen-Jonkers Original Article – Cancer Research Open access 03 June 2021 Pages: 2579 - 2590
A metal-free salalen ligand with anti-tumor and synergistic activity in resistant leukemia and solid tumor cells via mitochondrial pathway Sina M. HopffQifang WangAram Prokop Original Article – Cancer Research Open access 02 July 2021 Pages: 2591 - 2607
Lipopolysaccharides increase the risk of colorectal cancer recurrence and metastasis due to the induction of neutrophil extracellular traps after curative resection Wei-wei WangLipei WuAnquan Shang Original Article – Cancer Research 11 June 2021 Pages: 2609 - 2619
Effectiveness of low-dose radiation therapy to improve mortality of COVID-19 Hamid Ghaznavi Review – Clinical Oncology 05 July 2021 Pages: 2621 - 2624
Systemic therapy for recurrent and/or metastatic head and neck cancer: a population-based healthcare research study in Thuringia, Germany Lisa MorkramerMaren GeitnerOrlando Guntinas-Lichius Original Article – Clinical Oncology Open access 31 January 2021 Pages: 2625 - 2635
The effect of EML4-ALK break-apart ratio on crizotinib outcomes in non-small cell lung cancer harboring EML4-ALK rearrangement Burak BilginMehmet Ali Nahit ŞendurSadettin Kılıçkap Original Article – Clinical Oncology 02 February 2021 Pages: 2637 - 2643
Colonoscopy and polypectomy: beside age, size of polyps main factor for long-term risk of colorectal cancer in a screening population Kathrin HalfterLea BauerfeindJutta Engel Original Article – Clinical Oncology Open access 04 February 2021 Pages: 2645 - 2658
Clinical significance of FLT3-ITD/CEBPA mutations and minimal residual disease in cytogenetically normal acute myeloid leukemia after hematopoietic stem cell transplantation Hong WangXue-Qian LiYue Han Original Article – Clinical Oncology 07 February 2021 Pages: 2659 - 2670
Clinicopathological characteristics and outcomes in men with mesothelioma of the tunica vaginalis testis: analysis of published case-series data Josias Bastian GroggJordi Nicola FronzaroliChristian Daniel Fankhauser Original Article – Clinical Oncology Open access 09 February 2021 Pages: 2671 - 2679
Do proton pump inhibitors prevent Barrett’s esophagus progression to high-grade dysplasia and esophageal adenocarcinoma? An updated meta-analysis Yue ChenChenyu SunQin Zhou Original Article – Clinical Oncology 11 February 2021 Pages: 2681 - 2691
Improved oncologic outcomes by ablative radiotherapy in patients with bone metastasis from hepatocellular carcinoma Tae Hyung KimSangjoon ParkJinsil Seong Original Article – Clinical Oncology 13 February 2021 Pages: 2693 - 2700
Incidence of chemotherapy-induced nausea and vomiting among cancer patients receiving moderately to highly emetogenic chemotherapy in cancer centers in Sichuan, China Yu SunYuzhu ZhengJiang Zhu Original Article – Clinical Oncology 14 February 2021 Pages: 2701 - 2708
One-stitch method vs. traditional method of protective loop ileostomy for rectal cancer: the impact of BMI obesity Wenting PeiHuaiping CuiJizhun Zhang Original Article – Clinical Oncology 19 February 2021 Pages: 2709 - 2719
Coexistence of regression and tumor infiltrating lymphocytes is associated with more favorable survival in melanoma Faruk TasKayhan Erturk Original Article – Clinical Oncology 20 February 2021 Pages: 2721 - 2729
Real-world analysis of clinicopathological characteristics, survival rates, and prognostic factors in patients with melanoma brain metastases in China Yang WangBin LianJun Guo Original Article – Clinical Oncology 21 February 2021 Pages: 2731 - 2740
Overexpression of poliovirus receptor is associated with poor prognosis in head and neck squamous cell carcinoma patients Sun Min LimMin Hee HongHye Ryun Kim Original Article – Clinical Oncology 22 February 2021 Pages: 2741 - 2750
Efficacy and safety of transbronchial microwave ablation therapy under moderate sedation in malignant central airway obstruction patients with respiratory failure: a single-institution retrospective study Kosuke KashiwabaraShinji FujiiHiroshi Semba Original Article – Clinical Oncology 24 February 2021 Pages: 2751 - 2757
Multivariate analysis of prognostic factors in patients with nodular melanoma L. SusokM. StückerT. Gambichler Original Article – Clinical Oncology Open access 25 February 2021 Pages: 2759 - 2764
Cyberknife® hypofractionated stereotactic radiosurgery (CK-hSRS) as salvage treatment for brain metastases Sergej TelentschakDaniel RuessMaximilian Ruge Original Article – Clinical Oncology Open access 26 February 2021 Pages: 2765 - 2773
Early T-cell precursor acute lymphoblastic leukemia and other subtypes: a retrospective case report from a single pediatric center in China Xiaoming LiuYao ZouXiaofan Zhu Original Article – Clinical Oncology 02 March 2021 Pages: 2775 - 2788
Immune-related adverse events and immune checkpoint inhibitor tolerance on rechallenge in patients with irAEs: a single-center experience Vineel BhatlapenumarthiAnannya PatwariAntoine J. Harb Original Article – Clinical Oncology 28 March 2021 Pages: 2789 - 2800
Commentary on: Do proton pump inhibitors prevent Barrett’s esophagus progression to high-grade dysplasia and esophageal adenocarcinoma? An updated meta-analysis Jia LiYuwei Fan Letter to the Editor 04 June 2021 Pages: 2801 - 2802